Correction: Glial cell proteome using targeted quantitative methods for potential multi-diagnostic biomarkers

Affiliations

• ¹ New Drug Development Center, Heungdeok-gu, Chungbuk, Cheongju-si, 28160, Korea.
• ² School of Mechanical Engineering, Korea University, Seoul, 024841, Republic of Korea.
• ³ Institute of Chemical Engineering Convergence Systems, Korea University, Seoul, 02841, Republic of Korea.
• ⁴ Department of Neurosurgery, Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University, 28 Yeongeon-dong, Jongno-gu, Seoul, 03080, Korea.
• ⁵ Advanced Institute of Convergence Technology, Seoul National University (SNU), Suwon, 16229, Korea.
• ⁶ Department of Molecular Medicine & Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 28 Yeongeon-dong, Jongno-gu, Seoul, 03080, Korea.
• ⁷ Doping Control Center, Korea Institute of Science and Technology, Hwarang-ro 14-gil, Seongbuk-gu, Seoul, 02792, Korea.
• ⁸ Department of Chemical and Biological Engineering, Hanbat National University, Daejeon, 34158, Korea.
• ⁹ Department of Neurosurgery, Cancer Research Institute and Ischemic/Hypoxic Disease Institute, Seoul National University, 28 Yeongeon-dong, Jongno-gu, Seoul, 03080, Korea. paeksh@snu.ac.kr.
• ¹⁰ Advanced Institute of Convergence Technology, Seoul National University (SNU), Suwon, 16229, Korea. paeksh@snu.ac.kr.
• ¹¹ New Drug Development Center, Heungdeok-gu, Chungbuk, Cheongju-si, 28160, Korea. jichang011@kbiohealth.kr.